Bladder cancer in Africa: update

Area of Science:

• Oncology
• Epidemiology
• Public Health

Background:

• Bladder carcinoma is a significant health concern in Egypt and other African nations, representing a substantial portion of cancer cases.
• The disease predominantly affects males, with a median age of 46 at diagnosis, and is frequently associated with schistosomiasis (bilharziasis).
• Tumors are often diagnosed at advanced stages, with squamous cell carcinoma being the common histological type.

Purpose of the Study:

• To review the epidemiology, etiology, management, and outcomes of bladder carcinoma in the African context.
• To highlight the role of schistosomiasis and potential infectious agents in bladder carcinogenesis.
• To discuss current treatment strategies and future directions for research, including molecular genetic studies.

Main Methods:

• Review of existing literature and clinical data from the National Cancer Institute (NCI), Cairo, and other African countries.
• Analysis of epidemiological trends, risk factors (schistosomiasis, infections), and treatment modalities.
• Examination of survival rates and the impact of combined therapeutic approaches.

Main Results:

• Schistosomiasis is a major risk factor for bladder cancer in Africa, particularly squamous cell carcinoma.
• Management primarily involves surgery, with significant improvements in 5-year survival rates observed over decades.
• Adjuvant and neoadjuvant radiotherapy and chemotherapy have enhanced disease-free and overall survival when combined with surgery.

Conclusions:

• Bilharzial bladder cancer is a preventable malignancy, with parasite elimination as a primary prevention strategy.
• Chemoprevention using retinoids or COX-2 inhibitors presents a potential alternative for prevention.
• Further molecular genetic research is crucial for understanding tumorigenesis and identifying prognostic markers in bilharzial bladder cancer.